GB8909891D0
(en)
*
|
1989-04-28 |
1989-06-14 |
Riker Laboratories Inc |
Device
|
MY105368A
(en)
*
|
1990-03-02 |
1994-09-30 |
Glaxo Group Ltd |
Inhalation device.
|
GB9004781D0
(en)
*
|
1990-03-02 |
1990-04-25 |
Glaxo Group Ltd |
Device
|
US6536427B2
(en)
*
|
1990-03-02 |
2003-03-25 |
Glaxo Group Limited |
Inhalation device
|
SK280968B6
(sk)
*
|
1990-03-02 |
2000-10-09 |
Glaxo Group Limited |
Balenie medikamentu na použite v inhalačnom prístroji
|
FR2667509B1
(fr)
*
|
1990-10-04 |
1995-08-25 |
Valois |
Inhalateur a poudre, dispositif de conditionnement de microdoses de poudre sous forme de bandes adaptees a etre utilisees dans un inhalateur a poudre, et procede de fabrication de ces bandes.
|
JP3194956B2
(ja)
*
|
1992-09-11 |
2001-08-06 |
グラクソ、グループ、リミテッド |
吸入装置
|
SE9203570D0
(sv)
*
|
1992-11-27 |
1992-11-27 |
Astra Ab |
Inhaler for multiple use
|
US5896855A
(en)
*
|
1992-12-24 |
1999-04-27 |
Rhone-Poulenc Rorer Limited |
Multi dose inhaler apparatus
|
ES2115923T3
(es)
*
|
1992-12-24 |
1998-07-01 |
Rhone Poulenc Rorer Ltd |
Inhaladores.
|
GB9326574D0
(en)
*
|
1993-12-31 |
1994-03-02 |
King S College London |
Dry power inhalers
|
JPH07219571A
(ja)
*
|
1994-01-31 |
1995-08-18 |
Yukihiko Takino |
カラオケ曲目表示装置
|
PT101450B
(pt)
*
|
1994-02-02 |
1999-11-30 |
Hovione Produtos Farmaceuticos |
Novo dispositivo para inalacao
|
CN1195466C
(zh)
*
|
1994-08-30 |
2005-04-06 |
法玛西亚普强公司 |
眼睛治疗装置
|
GB9417399D0
(en)
|
1994-08-30 |
1994-10-19 |
Scherer Corp R P |
Ocular treatment device
|
DE29501527U1
(de)
*
|
1995-02-01 |
1995-03-30 |
Hugo Kern und Liebers GmbH & Co. Platinen- und Federnfabrik, 78713 Schramberg |
Vorrichtung zur Erzeugung inhalierbarer Wirkstoffpartikel
|
US5921237A
(en)
*
|
1995-04-24 |
1999-07-13 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
US5622166A
(en)
*
|
1995-04-24 |
1997-04-22 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler delivery system
|
SE9503344D0
(sv)
*
|
1995-09-27 |
1995-09-27 |
Astra Ab |
Inhalation device
|
EA001016B1
(ru)
|
1996-01-03 |
2000-08-28 |
Глаксо Груп Лимитед |
Ингаляционное устройство
|
US5857456A
(en)
*
|
1996-06-10 |
1999-01-12 |
Sarnoff Corporation |
Inhaler apparatus with an electronic means for enhanced release of dry powders
|
US5871010A
(en)
*
|
1996-06-10 |
1999-02-16 |
Sarnoff Corporation |
Inhaler apparatus with modified surfaces for enhanced release of dry powders
|
GB9626233D0
(en)
*
|
1996-12-18 |
1997-02-05 |
Chawla Brinda P S |
Medicament packaging and deliveery device
|
SE9700424D0
(sv)
*
|
1997-02-07 |
1997-02-07 |
Astra Ab |
Powder inhaler
|
US6006747A
(en)
*
|
1997-03-20 |
1999-12-28 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
CA2212430A1
(en)
*
|
1997-08-07 |
1999-02-07 |
George Volgyesi |
Inhalation device
|
US20060165606A1
(en)
*
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US5954047A
(en)
*
|
1997-10-17 |
1999-09-21 |
Systemic Pulmonary Development, Ltd. |
Methods and apparatus for delivering aerosolized medication
|
US6116238A
(en)
*
|
1997-12-02 |
2000-09-12 |
Dura Pharmaceuticals, Inc. |
Dry powder inhaler
|
JP2002535048A
(ja)
*
|
1999-01-22 |
2002-10-22 |
グラクソ グループ リミテッド |
吸入装置
|
GB9905538D0
(en)
|
1999-03-10 |
1999-05-05 |
Glaxo Group Ltd |
A device
|
US6601729B1
(en)
|
1999-03-26 |
2003-08-05 |
Papp Enterprises, Llc |
Automated portable medication radial dispensing apparatus and method using a carrier tape
|
GB9909357D0
(en)
|
1999-04-24 |
1999-06-16 |
Glaxo Group Ltd |
Medicament carrier
|
GB9909354D0
(en)
*
|
1999-04-24 |
1999-06-16 |
Glaxo Group Ltd |
Medicament carrier
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
US6730066B1
(en)
|
1999-08-03 |
2004-05-04 |
Pharmacia Ab |
Liquid delivery container
|
GB9925934D0
(en)
|
1999-11-03 |
1999-12-29 |
Glaxo Group Ltd |
Novel apparatus and process
|
US20010029947A1
(en)
*
|
1999-12-17 |
2001-10-18 |
Steve Paboojian |
Receptacles to facilitate the extraction of powders
|
US7171965B2
(en)
*
|
2000-02-01 |
2007-02-06 |
Valois S.A.S. |
Breath actuated dry powder inhaler and tape dose strip
|
GB0004456D0
(en)
*
|
2000-02-26 |
2000-04-19 |
Glaxo Group Ltd |
Medicament dispenser
|
DE10011120A1
(de)
|
2000-03-09 |
2001-09-13 |
Pfeiffer Erich Gmbh & Co Kg |
Spender für Medien
|
AU2001250901A1
(en)
*
|
2000-03-27 |
2001-10-08 |
Dura Pharmaceuticals, Inc. |
Containers for individual doses of an inhalable pharmaceutical
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US20030003057A1
(en)
*
|
2000-07-07 |
2003-01-02 |
Jeffry Weers |
Methods for administering leuprolide by inhalation
|
US7442388B2
(en)
*
|
2000-05-10 |
2008-10-28 |
Weers Jeffry G |
Phospholipid-based powders for drug delivery
|
US8404217B2
(en)
*
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
GB0012465D0
(en)
*
|
2000-05-24 |
2000-07-12 |
Glaxo Group Ltd |
Monitoring method
|
GB0013619D0
(en)
*
|
2000-06-06 |
2000-07-26 |
Glaxo Group Ltd |
Sample container
|
GB0014851D0
(en)
*
|
2000-06-16 |
2000-08-09 |
Glaxo Group Ltd |
Novel pharmaceutical formulation
|
GB0015034D0
(en)
|
2000-06-21 |
2000-08-09 |
Glaxo Group Ltd |
Inhalation device
|
PE20020163A1
(es)
*
|
2000-06-23 |
2002-03-04 |
Norton Healthcare Ltd |
Sistema presurizado de receptaculo para inhalador de medicamento
|
US7080644B2
(en)
*
|
2000-06-28 |
2006-07-25 |
Microdose Technologies, Inc. |
Packaging and delivery of pharmaceuticals and drugs
|
JP2004503338A
(ja)
*
|
2000-07-15 |
2004-02-05 |
グラクソ グループ リミテッド |
薬剤取り出し装置
|
WO2002009674A2
(en)
*
|
2000-07-28 |
2002-02-07 |
Inhale Therapeutic Systems, Inc. |
Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
|
AR032471A1
(es)
|
2000-08-05 |
2003-11-12 |
Glaxo Group Ltd |
Derivado de androstano y solvatos del mismo, su uso para la fabricacion de medicamentos, composiciones farmaceuticas que los comprenden, procesos para preparar tales derivados, intermediarios utiles en la preparacion de tales derivados, procesos para preparar tales intermediarios, y compuestos inter
|
US6759398B2
(en)
|
2000-08-05 |
2004-07-06 |
Smithkline Beecham Corporation |
Anti-inflammatory androstane derivative
|
WO2002013897A2
(en)
|
2000-08-14 |
2002-02-21 |
Advanced Inhalation Research, Inc. |
Inhalation device and method
|
AUPR020400A0
(en)
*
|
2000-09-19 |
2000-10-12 |
Glaxo Wellcome Australia Ltd |
Inhalation device
|
GB0026647D0
(en)
*
|
2000-10-31 |
2000-12-13 |
Glaxo Group Ltd |
Medicament dispenser
|
US20110301569A1
(en)
|
2001-01-20 |
2011-12-08 |
Gordon Wayne Dyer |
Methods and apparatus for the CVCS
|
GB0103630D0
(en)
|
2001-02-14 |
2001-03-28 |
Glaxo Group Ltd |
Chemical compounds
|
DE10111945B4
(de)
*
|
2001-03-13 |
2006-03-09 |
Alexander Christ |
Kapselspender
|
ATE381537T1
(de)
|
2001-03-22 |
2008-01-15 |
Glaxo Group Ltd |
Formanilid-derivative als beta2-adrenorezeptor- agonisten
|
US6766799B2
(en)
*
|
2001-04-16 |
2004-07-27 |
Advanced Inhalation Research, Inc. |
Inhalation device
|
CA2445839A1
(en)
|
2001-04-30 |
2002-11-07 |
Glaxo Group Limited |
Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
|
US20030051728A1
(en)
*
|
2001-06-05 |
2003-03-20 |
Lloyd Peter M. |
Method and device for delivering a physiologically active compound
|
FI20011317A0
(fi)
|
2001-06-20 |
2001-06-20 |
Orion Corp |
Jauheinhalaattori
|
JP2004537377A
(ja)
*
|
2001-08-09 |
2004-12-16 |
グラクソ グループ リミテッド |
製薬組成物を有する吸入装置
|
KR100912324B1
(ko)
|
2001-09-14 |
2009-08-14 |
글락소 그룹 리미티드 |
호흡기 질환 치료용 펜에탄올아민 유도체
|
WO2003024396A2
(en)
|
2001-09-17 |
2003-03-27 |
Glaxo Group Limited |
Dry powder medicament formulations
|
CA2460904C
(en)
|
2001-09-19 |
2011-03-22 |
Advent Pharmaceuticals Pty Ltd |
An inhaler for delivering metered doses of powdered medicament
|
GB0125135D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0125134D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0125132D0
(en)
*
|
2001-10-19 |
2001-12-12 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0127989D0
(en)
*
|
2001-11-22 |
2002-01-16 |
Glaxo Group Ltd |
Medicament dispensing system
|
GB0130055D0
(en)
*
|
2001-12-14 |
2002-02-06 |
Technology Innovation Ltd |
Medicament packaging
|
SI1458360T1
(sl)
|
2001-12-19 |
2011-08-31 |
Novartis Ag |
Pulmonalno dajanje aminoglikozidov
|
GB0217199D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
EP1467790A1
(en)
|
2002-01-25 |
2004-10-20 |
Glaxo Group Limited |
Medicament dispenser
|
GB0201677D0
(en)
*
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
AU2003216401A1
(en)
*
|
2002-03-01 |
2003-09-16 |
Glaxo Group Limited |
Rotary blending apparatus and system
|
EP1490031A1
(en)
*
|
2002-03-07 |
2004-12-29 |
Vectura Limited |
Fast melt multiparticulate formulations for oral delivery
|
GB0205572D0
(en)
*
|
2002-03-09 |
2002-04-24 |
Chawla Brinda P S |
Medicament delivery and packaging
|
WO2003095332A1
(en)
*
|
2002-03-26 |
2003-11-20 |
Glaxo Group Limited |
A method for forming a laminate assembly and products formed thereby
|
GR1004350B
(el)
*
|
2002-03-29 |
2003-09-26 |
|
Συσκευη εισπνοων ξηρης σκονης
|
US20030235538A1
(en)
*
|
2002-04-09 |
2003-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Method for the administration of an anticholinergic by inhalation
|
UA80123C2
(en)
*
|
2002-04-09 |
2007-08-27 |
Boehringer Ingelheim Pharma |
Inhalation kit comprising inhalable powder of tiotropium
|
GB0208608D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Composition
|
GB0208609D0
(en)
*
|
2002-04-13 |
2002-05-22 |
Glaxo Group Ltd |
Compositions
|
US7271197B2
(en)
|
2002-04-25 |
2007-09-18 |
Glaxo Group Limited |
Phenethanolamine derivatives
|
EP1497629A1
(en)
*
|
2002-04-25 |
2005-01-19 |
Glaxo Group Limited |
Magnetoacoustic sensor system and associated method for sensing environmental conditions
|
GB0209526D0
(en)
*
|
2002-04-26 |
2002-06-05 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0209528D0
(en)
*
|
2002-04-26 |
2002-06-05 |
Glaxo Group Ltd |
Medicament dispenser
|
AU2003269872A1
(en)
*
|
2002-05-15 |
2003-12-31 |
Glaxo Group Limited |
Microelectromechanical system and method for determining temperature and moisture profiles within pharmaceutical packaging
|
GB0216831D0
(en)
*
|
2002-07-19 |
2002-08-28 |
Glaxo Group Ltd |
Medicament dispenser
|
US20050268908A1
(en)
*
|
2002-07-25 |
2005-12-08 |
Bonney Stanley G |
Medicament dispenser
|
WO2004011068A1
(en)
|
2002-07-25 |
2004-02-05 |
Glaxo Group Limited |
Medicament dispenser
|
GB0217225D0
(en)
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0217196D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
GB0217198D0
(en)
*
|
2002-07-25 |
2002-09-04 |
Glaxo Group Ltd |
Medicament dispenser
|
WO2004024308A1
(en)
*
|
2002-09-13 |
2004-03-25 |
Glaxo Group Limited |
Coated blending system
|
GB0221493D0
(en)
*
|
2002-09-17 |
2002-10-23 |
Glaxo Group Ltd |
Method for loading a medicament dispenser with a medicament carrier
|
US6962266B2
(en)
*
|
2002-10-04 |
2005-11-08 |
Ecolab Inc. |
Method and apparatus for using a unit dose dispenser
|
ES2291733T3
(es)
*
|
2002-10-22 |
2008-03-01 |
Glaxo Group Limited |
Compuestos de ariletanolamina medicinales.
|
SI1556342T1
(sl)
|
2002-10-28 |
2008-08-31 |
Glaxo Group Ltd |
Fenetanolaminski derivat za zdravljenje respiratornih bolezni
|
WO2004060260A2
(en)
*
|
2002-12-18 |
2004-07-22 |
Glaxo Group Limited |
Drug delivery system with vented mouthpiece
|
US20040173211A1
(en)
*
|
2003-01-14 |
2004-09-09 |
Boehringer Ingelheim International Gmbh |
Powder inhaler
|
GB0303396D0
(en)
|
2003-02-14 |
2003-03-19 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0303870D0
(en)
*
|
2003-02-20 |
2003-03-26 |
Norton Healthcare Ltd |
Pre-metered dose magazine for breath-actuated dry powder inhaler
|
ATE477193T1
(de)
*
|
2003-03-15 |
2010-08-15 |
Brin Tech Internat Ltd |
Verpackung für arzneimittel
|
DE10317461A1
(de)
|
2003-04-16 |
2004-10-28 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Radioaktiv markierte Mikropartikel, Verfahren zu deren Herstellung und deren Verwendung
|
TWI328009B
(en)
|
2003-05-21 |
2010-08-01 |
Glaxo Group Ltd |
Quinoline derivatives as phosphodiesterase inhibitors
|
SE527069C2
(sv)
|
2003-06-19 |
2005-12-13 |
Mederio Ag |
Förfarande och anordning för administrering av läkemedelspulver
|
GB0315509D0
(en)
|
2003-07-02 |
2003-08-06 |
Meridica Ltd |
Dispensing device
|
GB0316335D0
(en)
*
|
2003-07-11 |
2003-08-13 |
Glaxo Group Ltd |
Pharmaceutical formulations
|
PE20050250A1
(es)
|
2003-07-17 |
2005-04-08 |
Glaxo Group Ltd |
Antagonistas de los receptores muscarinicos de la acetilcolina
|
GB0317374D0
(en)
|
2003-07-24 |
2003-08-27 |
Glaxo Group Ltd |
Medicament dispenser
|
AR046103A1
(es)
|
2003-10-14 |
2005-11-23 |
Glaxo Group Ltd |
Compuesto de 8-azoniabiciclo [3.2.1] octano,composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos y uso del compuesto para preparar dicha composicion
|
GB2407042B
(en)
*
|
2003-10-17 |
2007-10-24 |
Vectura Ltd |
Inhaler
|
EP1677796A4
(en)
|
2003-10-17 |
2006-12-27 |
Glaxo Group Ltd |
MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS
|
GB0324654D0
(en)
*
|
2003-10-22 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324886D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Medicinal compounds
|
GB0324897D0
(en)
*
|
2003-10-24 |
2003-11-26 |
Glaxo Group Ltd |
Composition
|
WO2005044187A2
(en)
*
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same
|
AR046225A1
(es)
|
2003-11-04 |
2005-11-30 |
Glaxo Group Ltd |
Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion
|
SE0303570L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Fukt-känslig medicinsk produkt
|
SE0303270L
(sv)
*
|
2003-12-03 |
2005-06-04 |
Microdrug Ag |
Metod för administration av tiotropium
|
CA2547782A1
(en)
*
|
2003-12-03 |
2005-06-16 |
Microdrug Ag |
Medical product containing tiotropium
|
US7631812B2
(en)
*
|
2003-12-10 |
2009-12-15 |
Williams Troy P |
Foldable transaction card systems
|
GB0329182D0
(en)
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Chemical compounds
|
MXPA06008621A
(es)
*
|
2004-02-06 |
2007-03-27 |
Microdose Technologies Inc |
Empaque de burbujas para usarse con un dispositivo de inhalacion.
|
GB2410947B
(en)
*
|
2004-02-11 |
2008-09-17 |
Cambridge Lab Ltd |
Pharmaceutical compounds
|
JP4825138B2
(ja)
|
2004-02-16 |
2011-11-30 |
グラクソ グループ リミテッド |
薬剤ディスペンサー用カウンター
|
US20090253908A1
(en)
*
|
2004-03-11 |
2009-10-08 |
Glaxo Group Limited |
Novel m3 muscarinic acetylchoine receptor antagonists
|
EP1725564A4
(en)
|
2004-03-17 |
2007-09-12 |
Glaxo Group Ltd |
ANTAGONISTS OF THE M3 MUSCARIN ACETYL CHOLIN RECEPTOR
|
EP1730104A1
(en)
|
2004-04-02 |
2006-12-13 |
Glaxo Group Limited |
Chemical process and new crystalline form
|
US7828147B2
(en)
*
|
2004-04-24 |
2010-11-09 |
Inrange Systems, Inc. |
Multi-layer medication carrier
|
JP2007535036A
(ja)
*
|
2004-04-24 |
2007-11-29 |
インレンジ システムズ、インク. |
統合された非連続的な遠隔薬剤管理およびコンプライアンスシステム
|
UY28871A1
(es)
|
2004-04-27 |
2005-11-30 |
Glaxo Group Ltd |
Antagonistas del receptor de acetilcolina muscarinico
|
EP1747219A4
(en)
|
2004-05-13 |
2010-05-26 |
Glaxo Group Ltd |
Antagonists of muscarinic acetylcholine receptor
|
AR049384A1
(es)
|
2004-05-24 |
2006-07-26 |
Glaxo Group Ltd |
Derivados de purina
|
EP1765405A1
(en)
|
2004-05-31 |
2007-03-28 |
Laboratorios Almirall, S.A. |
Combinations comprising antimuscarinic agents and corticosteroids
|
ES2257152B1
(es)
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
SE530006C2
(sv)
*
|
2004-06-18 |
2008-02-05 |
Mederio Ag |
Inhalator som använder balja
|
SE0401654D0
(sv)
*
|
2004-06-24 |
2004-06-24 |
Astrazeneca Ab |
A support structure for a medicament
|
FR2872798B1
(fr)
*
|
2004-07-09 |
2007-10-05 |
Valois Sas |
Ensemble de blisters pour dispositif d'inhalation
|
GB0418278D0
(en)
|
2004-08-16 |
2004-09-15 |
Glaxo Group Ltd |
Medicament dispenser
|
EP1819388A2
(en)
*
|
2004-10-06 |
2007-08-22 |
Boehringer Ingelheim International GmbH |
Dispensing device, storage device and method for dispensing powder
|
JP2008519984A
(ja)
*
|
2004-11-12 |
2008-06-12 |
グラクソ グループ リミテッド |
音響変換器を備えるセンサシステム
|
GB0427853D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
GB0427858D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Manifold for use in medicament dispenser
|
GB0427856D0
(en)
*
|
2004-12-20 |
2005-01-19 |
Glaxo Group Ltd |
Maniflod for use in medicament dispenser
|
US20080125462A1
(en)
*
|
2005-01-11 |
2008-05-29 |
Lois Elizabeth Vernon |
Cinnamate Salts Of A Beta-2 Adrenergic Agonist
|
FR2881117B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
FR2881111B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
FR2881119B1
(fr)
*
|
2005-01-25 |
2010-07-30 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
FR2881118B1
(fr)
*
|
2005-01-25 |
2007-04-20 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
JP2008529773A
(ja)
*
|
2005-02-10 |
2008-08-07 |
グラクソ グループ リミテッド |
医薬製剤に使用するためのラクトース粒子の結晶化方法
|
ES2613391T3
(es)
|
2005-02-10 |
2017-05-24 |
Glaxo Group Limited |
Procedimientos de fabricación de lactosa que utilizan técnicas de preclasificación y formulaciones farmacéuticas formadas a partir de la misma
|
AR053450A1
(es)
|
2005-03-25 |
2007-05-09 |
Glaxo Group Ltd |
Derivados de 3,4-dihidro-pirimido(4,5-d)pirimidin-2-(1h)-ona 1,5,7 trisustituidos como inhibidores de la quinasa p38
|
PE20100737A1
(es)
|
2005-03-25 |
2010-11-27 |
Glaxo Group Ltd |
Nuevos compuestos
|
EP1879579A1
(en)
*
|
2005-05-04 |
2008-01-23 |
Boehringer Ingelheim International GmbH |
Inhalation device containing plural doses of a pharmaceutical composition
|
GB0509952D0
(en)
*
|
2005-05-16 |
2005-06-22 |
Glaxo Group Ltd |
Fault indicator
|
ES2265276B1
(es)
|
2005-05-20 |
2008-02-01 |
Laboratorios Almirall S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
|
GB0514501D0
(en)
*
|
2005-07-14 |
2005-08-24 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
GB0514809D0
(en)
|
2005-07-19 |
2005-08-24 |
Glaxo Group Ltd |
Compounds
|
DE102005035705A1
(de)
|
2005-07-27 |
2007-02-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Arzneimittelblister
|
GB0515584D0
(en)
|
2005-07-28 |
2005-09-07 |
Glaxo Group Ltd |
Medicament dispenser
|
EP1937230A4
(en)
*
|
2005-08-02 |
2009-08-26 |
Glaxo Group Ltd |
M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS
|
US20080275079A1
(en)
*
|
2005-08-02 |
2008-11-06 |
Glaxo Group Limited |
M3 Muscarinic Acetylcholine Receptor Antagonists
|
GB0516168D0
(en)
*
|
2005-08-05 |
2005-09-14 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
JP2009504768A
(ja)
|
2005-08-18 |
2009-02-05 |
グラクソ グループ リミテッド |
ムスカリン性アセチルコリン受容体アンタゴニスト
|
TWI274641B
(en)
*
|
2005-08-30 |
2007-03-01 |
Rexon Ind Corp Ltd |
Cutting machine
|
US20070068837A1
(en)
*
|
2005-09-29 |
2007-03-29 |
D Angelis Bruno S |
Wound dressing dispenser
|
GB0521563D0
(en)
|
2005-10-21 |
2005-11-30 |
Glaxo Group Ltd |
Novel compounds
|
AR058289A1
(es)
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Colector para ser usado en dispensador de medicamento
|
AR058290A1
(es)
*
|
2005-12-12 |
2008-01-30 |
Glaxo Group Ltd |
Dispensador de medicamento
|
US7987845B2
(en)
|
2006-01-31 |
2011-08-02 |
Oriel Therapeutics, Inc. |
Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
|
JP5188991B2
(ja)
*
|
2006-03-03 |
2013-04-24 |
エスティーシー.ユーエヌエム |
空力弾性分配メカニズムを有するドライパウダー吸入器
|
US8127763B2
(en)
*
|
2006-03-03 |
2012-03-06 |
Stc.Unm |
Dry powder inhaler with aeroelastic dispersion mechanism
|
GB0605150D0
(en)
*
|
2006-03-14 |
2006-04-26 |
Glaxo Group Ltd |
Counter For Use With A Medicament Dispenser
|
EP1844808A1
(de)
*
|
2006-04-13 |
2007-10-17 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG |
Medikamenten-Ausgabevorrichtung
|
EP1844809A1
(de)
*
|
2006-04-13 |
2007-10-17 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Medikamentenmagazin für einen Inhalator, sowie Mehrdosispulverinhalator
|
AU2007242851A1
(en)
|
2006-04-20 |
2007-11-01 |
Glaxo Group Limited |
Novel compounds
|
GR1005668B
(el)
*
|
2006-05-09 |
2007-10-02 |
|
Συσκευη εισπνοων ξηρης σκονης για την ταυτοχρονη χορηγηση περισσοτερων απο μιας φαρμακευτικων ουσιων
|
GR1005620B
(el)
*
|
2006-05-09 |
2007-09-03 |
|
Βελτιωση συσκευης εισπνοων ξηρης σκονης
|
DE102006023662A1
(de)
*
|
2006-05-18 |
2007-11-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Inhalator
|
US9457161B2
(en)
|
2006-05-18 |
2016-10-04 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
GB0611587D0
(en)
|
2006-06-12 |
2006-07-19 |
Glaxo Group Ltd |
Novel compounds
|
FR2904229B1
(fr)
*
|
2006-07-25 |
2008-10-10 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
CA2659539A1
(en)
|
2006-08-01 |
2008-02-07 |
Glaxo Group Limited |
Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
|
NZ576637A
(en)
|
2006-10-25 |
2012-05-25 |
Novartis Ag |
Powder dispersion apparatus with and mediciment receptacles that are cut open using an elliptical arc shaped knife blade oriented to yaw between 4 and 12 degrees
|
GB0622827D0
(en)
|
2006-11-15 |
2006-12-27 |
Glaxo Group Ltd |
Sheet driver for use in a drug dispenser
|
EP1925295A1
(de)
|
2006-11-22 |
2008-05-28 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Stabile Pulverformulierung enthaltend ein Anticholinergikum
|
WO2008081132A2
(fr)
*
|
2006-12-11 |
2008-07-10 |
Valois Sas |
Dispositif de distribution de produit fluide
|
FR2909643B1
(fr)
*
|
2006-12-11 |
2011-03-04 |
Valois Sas |
Dispositif de distribution de produit fluide
|
US20080163610A1
(en)
*
|
2007-01-05 |
2008-07-10 |
Matthew Thomas Baird |
Method and system for regenerating exhaust system filtering and catalyst components using variable high engine idle
|
ES2306595B1
(es)
|
2007-02-09 |
2009-09-11 |
Laboratorios Almirall S.A. |
Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
|
ES2320955B1
(es)
|
2007-03-02 |
2010-03-16 |
Laboratorios Almirall S.A. |
Nuevos derivados de 3-((1,2,4)triazolo(4,3-a)piridin-7-il)benzamida.
|
US8616199B2
(en)
|
2007-03-16 |
2013-12-31 |
Canon Kabushiki Kaisha |
Inhaler and ejection head unit attachable to the inhaler
|
AR065804A1
(es)
|
2007-03-23 |
2009-07-01 |
Smithkline Beecham Corp |
Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
|
JP5198801B2
(ja)
*
|
2007-05-30 |
2013-05-15 |
株式会社吉野工業所 |
吸引式投薬器
|
WO2008156586A2
(en)
*
|
2007-06-12 |
2008-12-24 |
Alkermes, Inc. |
Inhalation device for powdered substances
|
EP2011536A1
(en)
*
|
2007-07-06 |
2009-01-07 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Inhaler
|
JP2010532241A
(ja)
*
|
2007-07-06 |
2010-10-07 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
吸入器
|
ES2569359T3
(es)
*
|
2007-07-06 |
2016-05-10 |
Vectura Delivery Devices Limited |
Inhalador
|
ES2320961B1
(es)
|
2007-11-28 |
2010-03-17 |
Laboratorios Almirall, S.A. |
Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
|
KR20100103834A
(ko)
|
2007-12-20 |
2010-09-28 |
아스트라제네카 아베 |
분말 854를 탈응집하는 장치 및 방법
|
AU2009206801B2
(en)
*
|
2008-01-23 |
2011-07-07 |
Astrazeneca Ab |
A medicament-containing dispenser provided with a display for presenting indicia to a user
|
EP2082758A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
EP2082759A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
EP2082764A1
(en)
*
|
2008-01-24 |
2009-07-29 |
Boehringer Ingelheim International GmbH |
Inhaler
|
EP2096105A1
(en)
|
2008-02-28 |
2009-09-02 |
Laboratorios Almirall, S.A. |
Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
EP2108641A1
(en)
|
2008-04-11 |
2009-10-14 |
Laboratorios Almirall, S.A. |
New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
|
EP2113503A1
(en)
|
2008-04-28 |
2009-11-04 |
Laboratorios Almirall, S.A. |
New substituted indolin-2-one derivatives and their use as p39 mitogen-activated kinase inhibitors
|
GB0810857D0
(en)
*
|
2008-06-13 |
2008-07-23 |
Cambridge Lab Ireland Ltd |
Pharmaceutical compounds
|
WO2010008523A1
(en)
|
2008-07-13 |
2010-01-21 |
Map Pharmaceuticals, Inc. |
Methods and apparatus for delivering aerosolized medication
|
US20110053866A1
(en)
*
|
2008-08-12 |
2011-03-03 |
Biovail Laboratories International (Barbados) S.R.L. |
Pharmaceutical compositions
|
GB2462611A
(en)
*
|
2008-08-12 |
2010-02-17 |
Cambridge Lab |
Pharmaceutical composition comprising tetrabenazine
|
GB2463283A
(en)
*
|
2008-09-08 |
2010-03-10 |
Cambridge Lab |
3,11b-cis-dihydrotetrabenazine for use in treating asthma
|
GB2463452A
(en)
*
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
|
GB2463451A
(en)
|
2008-09-08 |
2010-03-17 |
Cambridge Lab |
3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
|
CN102159270B
(zh)
|
2008-09-26 |
2014-07-02 |
奥里尔治疗公司 |
一种带有具有气道盘沟槽的气道盘的吸入器和相关的气道盘和方法
|
CA2732840C
(en)
|
2008-09-26 |
2016-07-05 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with dual piercing members and related devices and methods
|
WO2010036355A2
(en)
*
|
2008-09-26 |
2010-04-01 |
Oriel Therapeutics, Inc. |
Inhaler mechanisms with radially biased piercers and related methods
|
US9050427B2
(en)
*
|
2008-09-30 |
2015-06-09 |
Oriel Therapeutics, Inc. |
Dry powder inhalers with multi-facet surface deagglomeration chambers and related devices and methods
|
ES2561899T3
(es)
*
|
2008-10-01 |
2016-03-01 |
Oriel Therapeutics, Inc. |
Inhaladores de polvo seco con mecanismos de perforación giratorios y dispositivos y métodos relacionados
|
WO2010042036A1
(en)
*
|
2008-10-08 |
2010-04-15 |
Astrazeneca Ab |
Inhaler with audible indicator means
|
GB201020130D0
(en)
*
|
2010-11-26 |
2011-01-12 |
Vectura Delivery Devices Ltd |
Inhaler
|
EP2196465A1
(en)
|
2008-12-15 |
2010-06-16 |
Almirall, S.A. |
(3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
|
EP2198908A1
(en)
*
|
2008-12-19 |
2010-06-23 |
Boehringer Ingelheim International Gmbh |
Inhaler
|
UY32297A
(es)
|
2008-12-22 |
2010-05-31 |
Almirall Sa |
Sal mesilato de 5-(2-{[6-(2,2-difluoro-2-fenilitoxi) hexil]amino}-1-hidroxietil)-8-hidroxiquinolin-2( 1h)-ona como agonista del receptor b(beta)2 acrenérgico
|
BRPI1006162A2
(pt)
|
2009-01-13 |
2019-09-24 |
Glaxo Group Ltd |
"composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto".
|
NZ574666A
(en)
*
|
2009-02-05 |
2009-04-30 |
Nexus6 Ltd |
A medicament inhaler holder that uses optical means to count and display the number of doses used
|
WO2010094643A1
(en)
|
2009-02-17 |
2010-08-26 |
Glaxo Group Limited |
Quinoline derivatives and their uses for rhinitis and urticaria
|
EP2221055A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one for the treatment of lung function
|
EP2221297A1
(en)
|
2009-02-18 |
2010-08-25 |
Almirall, S.A. |
5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one and its use in the treatment of pulmonary diseases
|
DK2400950T3
(da)
|
2009-02-26 |
2019-07-29 |
Glaxo Group Ltd |
Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
|
EP2226323A1
(en)
|
2009-02-27 |
2010-09-08 |
Almirall, S.A. |
New tetrahydropyrazolo[3,4-c]isoquinolin-5-amine derivatives
|
EP2228368A1
(en)
|
2009-03-12 |
2010-09-15 |
Almirall, S.A. |
Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
|
UY32571A
(es)
|
2009-04-24 |
2010-11-30 |
Glaxo Group Ltd |
Compuestos derivados de pirazol amida
|
WO2010122088A1
(en)
|
2009-04-24 |
2010-10-28 |
Glaxo Group Limited |
Pyrazole and triazole carboxamides as crac channel inhibitors
|
DE202009006141U1
(de)
|
2009-04-25 |
2009-08-27 |
Boehringer Ingelheim International Gmbh |
Inhalator
|
PT2427166E
(pt)
|
2009-05-07 |
2014-01-20 |
Gea Pharma Systems Ltd |
Módulo de produção de comprimidos e método para a produção contínua de comprimidos
|
ES2506166T3
(es)
|
2009-05-18 |
2014-10-13 |
Norton Healthcare Limited |
Inhalador de polvo seco
|
EP3332826A1
(en)
|
2009-05-18 |
2018-06-13 |
Adamis Pharmaceuticals Corporation |
Dry powder inhaler with a dose counter
|
PL2432533T3
(pl)
|
2009-05-18 |
2015-11-30 |
Norton Healthcare Ltd |
Inhalator suchego proszku
|
JP5720009B2
(ja)
|
2009-05-18 |
2015-05-20 |
アダミス ファーマシューティカルズ コーポレーション |
ドライパウダー吸入器
|
WO2010136134A1
(en)
|
2009-05-18 |
2010-12-02 |
Norton Healthcare Limited |
Dry-powder inhaler
|
EP2432536B1
(en)
*
|
2009-05-21 |
2018-07-04 |
MicroDose Therapeutx, Inc. |
Rotary cassette system for dry powder inhaler
|
US8985101B2
(en)
|
2009-05-21 |
2015-03-24 |
Microdose Therapeutx, Inc. |
Method and device for clamping a blister within a dry powder inhaler
|
JP2012530140A
(ja)
|
2009-06-16 |
2012-11-29 |
メルク・シャープ・アンド・ドーム・コーポレーション |
グルココルチコイド受容体アゴニストとしての新規[3,2−c]ヘテロアリールステロイド、組成物およびこの使用
|
EP2448623B1
(en)
|
2009-07-01 |
2017-12-20 |
AstraZeneca AB |
Dispenser and method for entraining powder in an airflow
|
WO2011129785A1
(en)
*
|
2010-04-13 |
2011-10-20 |
Mahmut Bilgic |
Dry powder inhaler mouthpiece button
|
GB0919431D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
AU2010314395B2
(en)
|
2009-11-05 |
2015-04-09 |
Glaxosmithkline Llc |
Benzodiazepine bromodomain inhibitor
|
EP3050885B1
(en)
|
2009-11-05 |
2017-10-18 |
GlaxoSmithKline LLC |
Benzodiazepine bromodomain inhibitor
|
GB0919434D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919426D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919423D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Novel compounds
|
GB0919432D0
(en)
|
2009-11-05 |
2009-12-23 |
Glaxosmithkline Llc |
Use
|
WO2011054851A1
(en)
|
2009-11-05 |
2011-05-12 |
Glaxosmithkline Llc |
Novel process
|
EP2322176A1
(en)
|
2009-11-11 |
2011-05-18 |
Almirall, S.A. |
New 7-phenyl-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives
|
EP2498848A2
(en)
|
2009-11-12 |
2012-09-19 |
Stc.Unm |
Dry powder inhaler with flutter dispersion member
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
TR200909791A2
(tr)
|
2009-12-25 |
2011-07-21 |
Bi̇lgi̇ç Mahmut |
Salmeterol ve flutikazon içeren farmasötik bileşim@
|
WO2011085022A1
(en)
|
2010-01-05 |
2011-07-14 |
Microdose Therapeutx, Inc. |
Inhalation device and method
|
US9046403B2
(en)
*
|
2010-02-01 |
2015-06-02 |
Mallinckrodt Llc |
Systems and methods for managing use of a medicament
|
US8490795B2
(en)
|
2010-02-01 |
2013-07-23 |
Mallinckrodt Llc |
Container and method for facilitating disposal of unused pharmaceutical product
|
EP2380890A1
(en)
|
2010-04-23 |
2011-10-26 |
Almirall, S.A. |
New 7,8-dihydro-1,6-naphthyridin-5(6h)-one-derivatives as PDE4 inhibitors
|
GB201007203D0
(en)
|
2010-04-29 |
2010-06-16 |
Glaxo Group Ltd |
Novel compounds
|
EP2386555A1
(en)
|
2010-05-13 |
2011-11-16 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
|
EP2394998A1
(en)
|
2010-05-31 |
2011-12-14 |
Almirall, S.A. |
3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
|
FR2961186B1
(fr)
*
|
2010-06-11 |
2012-07-13 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
WO2011161031A1
(en)
|
2010-06-22 |
2011-12-29 |
Glaxosmithkline Llc |
Benzotriazolodiazepine compounds inhibitors of bromodomains
|
FR2962345B1
(fr)
|
2010-07-09 |
2013-06-21 |
Valois Sas |
Inhalateur unidose de poudre seche pour blister pelable.
|
ES2535701T3
(es)
*
|
2010-07-21 |
2015-05-14 |
Astrazeneca Ab |
Inhalador
|
WO2012025473A1
(en)
|
2010-08-24 |
2012-03-01 |
Glaxo Group Limited |
Cc.chemokine receptor 4 antagonists
|
WO2012025474A1
(en)
|
2010-08-24 |
2012-03-01 |
Glaxo Group Limited |
Indazole compounds
|
AU2011298315B2
(en)
|
2010-08-31 |
2014-08-28 |
Glaxo Group Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
ES2845185T3
(es)
|
2010-08-31 |
2021-07-26 |
Glaxosmithkline Ip Dev Ltd |
Productos farmacológicos para la inhalación de polvo seco que presentan propiedades de control de la humedad y procedimientos de administración de los mismos
|
EP2441755A1
(en)
|
2010-09-30 |
2012-04-18 |
Almirall, S.A. |
Pyridine- and isoquinoline-derivatives as Syk and JAK kinase inhibitors
|
ES2532213T3
(es)
|
2010-10-21 |
2015-03-25 |
Glaxo Group Limited |
Compuestos de pirazol que actúan contra afecciones alérgicas, inmunitarias e inflamatorias
|
WO2012052459A1
(en)
|
2010-10-21 |
2012-04-26 |
Glaxo Group Limited |
Pyrazole compounds acting against allergic, inflammatory and immune disorders
|
US9297813B2
(en)
|
2010-11-11 |
2016-03-29 |
Agency For Science, Technology And Research |
Targeting metabolic enzymes in human cancer
|
EP2457900A1
(en)
|
2010-11-25 |
2012-05-30 |
Almirall, S.A. |
New pyrazole derivatives having CRTh2 antagonistic behaviour
|
EP2463289A1
(en)
|
2010-11-26 |
2012-06-13 |
Almirall, S.A. |
Imidazo[1,2-b]pyridazine derivatives as JAK inhibitors
|
US8561609B2
(en)
|
2010-12-07 |
2013-10-22 |
Respira Therapeutics, Inc. |
Dry powder inhaler
|
EP2489663A1
(en)
|
2011-02-16 |
2012-08-22 |
Almirall, S.A. |
Compounds as syk kinase inhibitors
|
US20140005188A1
(en)
|
2011-03-11 |
2014-01-02 |
Glaxo Group Limited |
Pyrido[3,4-b]pyrazine derivatives as syk inhibitors
|
GB201104153D0
(en)
|
2011-03-11 |
2011-04-27 |
Glaxo Group Ltd |
Novel compounds
|
US8834411B2
(en)
|
2011-04-06 |
2014-09-16 |
Mystic Pharmaceuticals, Inc. |
Medical devices for dispensing powders
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
GB201106750D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
GB201106799D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
GB201106743D0
(en)
|
2011-04-21 |
2011-06-01 |
Glaxosmithkline Llc |
Novel compounds
|
EP2518070A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as PI3K inhibitors
|
EP2518071A1
(en)
|
2011-04-29 |
2012-10-31 |
Almirall, S.A. |
Imidazopyridine derivatives as PI3K inhibitors
|
GB201107325D0
(en)
|
2011-05-04 |
2011-06-15 |
Glaxosmithkline Llc |
Novel compounds
|
EP2526945A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
New CRTH2 Antagonists
|
EP2527344A1
(en)
|
2011-05-25 |
2012-11-28 |
Almirall, S.A. |
Pyridin-2(1H)-one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
|
RU2013153202A
(ru)
|
2011-06-08 |
2015-07-20 |
Глаксо Груп Лимитед |
Композиции для ингалятора сухого порошка, содержащие умеклидиний
|
PE20141048A1
(es)
|
2011-06-08 |
2014-09-08 |
Glaxo Group Ltd |
Combinacion que comprende umeclidinio y un corticosteroide
|
EP2548863A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists.
|
EP2548876A1
(en)
|
2011-07-18 |
2013-01-23 |
Almirall, S.A. |
New CRTh2 antagonists
|
EP2554544A1
(en)
|
2011-08-01 |
2013-02-06 |
Almirall, S.A. |
Pyridin-2(1h)-one derivatives as jak inhibitors
|
GB201114103D0
(en)
|
2011-08-17 |
2011-09-28 |
Glaxosmithkline Llc |
Novel compounds
|
GB201116641D0
(en)
|
2011-09-27 |
2011-11-09 |
Glaxo Group Ltd |
Novel compounds
|
EP2578570A1
(en)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
|
EP2592077A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
EP2592078A1
(en)
|
2011-11-11 |
2013-05-15 |
Almirall, S.A. |
New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
|
WO2013114371A1
(en)
|
2012-02-01 |
2013-08-08 |
Protalix Ltd. |
Dry powder formulations of dnase i
|
US10463815B2
(en)
|
2012-02-21 |
2019-11-05 |
Respira Therapeutics, Inc. |
Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
|
GB2499597A
(en)
*
|
2012-02-21 |
2013-08-28 |
Innovata Biomed Ltd |
Dry powder inhaler with stepped rotation of metering member
|
EP2641900A1
(en)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
|
EP2647627A1
(en)
|
2012-04-02 |
2013-10-09 |
Almirall, S.A. |
Salts of 5-[(1r)-2-({2-[4-(2,2-difluoro-2-phenylethoxy)phenyl] ethyl}amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-one.
|
DE102012104850A1
(de)
|
2012-04-05 |
2013-10-10 |
Alfred Von Schuckmann |
Vorrichtung zur portionierten Ausgabe von Medikamenten
|
KR20140147891A
(ko)
|
2012-04-13 |
2014-12-30 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
응집체 입자
|
GB201207406D0
(en)
|
2012-04-27 |
2012-06-13 |
Glaxo Group Ltd |
Novel compounds
|
AR090847A1
(es)
|
2012-04-27 |
2014-12-10 |
Glaxo Group Ltd |
Compuestos moduladores del receptor huerfano retinoideo (ror)
|
EP2662105B1
(de)
|
2012-05-09 |
2017-01-18 |
Boehringer Ingelheim International GmbH |
Zerstäuber
|
FR2990872B1
(fr)
*
|
2012-05-24 |
2015-05-15 |
Valois Sas |
Dispositif de distribution de produit fluide.
|
EP2666465A1
(en)
|
2012-05-25 |
2013-11-27 |
Almirall, S.A. |
Novel dosage and formulation
|
WO2013176639A1
(en)
*
|
2012-05-25 |
2013-11-28 |
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi |
Inhaler device with an improved blister advancement mechanism
|
EA201492044A1
(ru)
*
|
2012-05-25 |
2015-05-29 |
Арвен Айлак Санайи Ве Тиджарет А.С. |
Ингалятор, содержащий внутренний корпус, имеющий канал для воздуха
|
GB2502350A
(en)
|
2012-05-25 |
2013-11-27 |
Vectura Delivery Devices Ltd |
Inhaler having means to control the force applied to an actuating lever
|
EP2668941A1
(en)
|
2012-05-31 |
2013-12-04 |
Almirall, S.A. |
Novel dosage form and formulation of abediterol
|
WO2014006135A2
(en)
|
2012-07-05 |
2014-01-09 |
Glaxo Group Limited |
Inhaler device
|
WO2014060431A1
(en)
|
2012-10-16 |
2014-04-24 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
EP2738172A1
(en)
|
2012-11-28 |
2014-06-04 |
Almirall, S.A. |
New bicyclic compounds as crac channel modulators
|
CN104853758A
(zh)
|
2012-11-28 |
2015-08-19 |
英特赛普特医药品公司 |
肺部疾病的治疗
|
JP5350530B1
(ja)
*
|
2012-12-07 |
2013-11-27 |
ニップファーマ株式会社 |
薬剤吸入デバイス
|
AU2013360866A1
(en)
|
2012-12-18 |
2015-07-02 |
Almirall, S.A. |
New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activity
|
TW201446767A
(zh)
|
2013-02-15 |
2014-12-16 |
Almirall Sa |
作為磷脂肌醇3-激酶抑製劑之吡咯並三嗪衍生物
|
UA118549C2
(uk)
|
2013-03-14 |
2019-02-11 |
Ґлаксосмітклайн Інтеллекчуал Проперті (№ 2) Лімітед |
2,3-дизаміщені похідні 1-ацил-4-аміно-1,2,3,4-тетрагідрохіноліну та їх застосування як інгібіторів бромодомену
|
CA2903357A1
(en)
|
2013-03-14 |
2014-09-18 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Furanopyridines as bromodomain lnhibitors
|
GB201305668D0
(en)
|
2013-03-28 |
2013-05-15 |
Glaxosmithkline Ip Dev Ltd |
Avs6 Integrin Antagonists
|
JP6105373B2
(ja)
*
|
2013-04-25 |
2017-03-29 |
株式会社吉野工業所 |
吸引器具
|
JP5985434B2
(ja)
*
|
2013-04-25 |
2016-09-06 |
株式会社吉野工業所 |
吸引器具
|
RU2544801C2
(ru)
*
|
2013-06-11 |
2015-03-20 |
Открытое Акционерное Общество "Фармацевтическая Фабрика Санкт-Петербурга" |
Порошковый ингалятор
|
EP2848615A1
(en)
|
2013-07-03 |
2015-03-18 |
Almirall, S.A. |
New pyrazole derivatives as CRAC channel modulators
|
USD737425S1
(en)
|
2013-07-09 |
2015-08-25 |
Celon Pharma S.A. |
Inhaler
|
USD759163S1
(en)
|
2013-07-30 |
2016-06-14 |
Celon Pharma S.A. |
Label for an inhaler
|
USD746378S1
(en)
|
2013-07-30 |
2015-12-29 |
Celon Pharma S.A. |
Label for an inhaler
|
CN103624401B
(zh)
*
|
2013-08-20 |
2016-03-02 |
南京理工大学 |
立式定量控制的自动***复合***铺放装置
|
WO2015091285A1
(en)
|
2013-12-19 |
2015-06-25 |
Almirall S.A. |
Dosage formulation comprising salmeterol and fluticasone propionate
|
CN106061532A
(zh)
|
2013-12-23 |
2016-10-26 |
格兰马克药品有限公司 |
干粉吸入器
|
KR20170003673A
(ko)
|
2014-05-12 |
2017-01-09 |
글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 |
감염성 질환을 치료하기 위한 다니릭신을 포함하는 약제 조성물
|
WO2015181262A1
(en)
|
2014-05-28 |
2015-12-03 |
Glaxosmithkline Intellectual Property Development Limited |
Fluticasone furoate in the treatment of copd
|
EP2957552B1
(en)
|
2014-06-16 |
2020-01-22 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Vilanterol formulations
|
EP2957553A1
(en)
|
2014-06-16 |
2015-12-23 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical formulations of vilanterol
|
EP2957550A1
(en)
|
2014-06-16 |
2015-12-23 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Pharmaceutical formulations comprising vilanterol
|
TR201407010A2
(tr)
|
2014-06-16 |
2015-12-21 |
Arven Ilac Sanayi Ve Ticaret Anonim Sirketi |
Vilanterol formülasyonları.
|
US20170304459A1
(en)
|
2014-10-10 |
2017-10-26 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for inhalation delivery of conjugated oligonucleotide
|
US9550032B2
(en)
*
|
2014-10-12 |
2017-01-24 |
Kendra Baldwin |
Wearable wrist inhaler
|
DK3212212T3
(da)
|
2014-10-31 |
2020-12-21 |
Univ Monash |
Pulverformulering
|
EP3244952A4
(en)
|
2015-01-14 |
2018-11-14 |
Respira Therapeutics, Inc. |
Powder dispersion methods and devices
|
GB201503720D0
(en)
|
2015-03-05 |
2015-04-22 |
Glaxosmithkline Ip No 2 Ltd |
Chemical compound
|
TW201643179A
(zh)
|
2015-03-11 |
2016-12-16 |
葛蘭素史克智慧財產發展有限公司 |
Tslp結合蛋白
|
USD767114S1
(en)
|
2015-03-18 |
2016-09-20 |
Amneal Pharmaceuticals Company Gmbh |
Inhalation device
|
USD769439S1
(en)
|
2015-03-18 |
2016-10-18 |
Amneal Pharmaceuticals Company Gmbh |
Inhalation device
|
GB201504689D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
WO2016161830A1
(zh)
*
|
2015-04-09 |
2016-10-13 |
正大天晴药业集团股份有限公司 |
药物释放带
|
CN106139335B
(zh)
*
|
2015-04-09 |
2022-12-16 |
正大天晴药业集团股份有限公司 |
一种药粉释放装置
|
TWI597079B
(zh)
*
|
2015-04-10 |
2017-09-01 |
微劑量醫療公司 |
泡殼帶進給機構
|
MA41938A
(fr)
|
2015-04-21 |
2018-02-28 |
Almirall Sa |
Dérivés hétérocycliques amino-substitués utilisés comme inhibiteurs des canaux sodiques
|
AU364719S
(en)
|
2015-05-20 |
2015-10-14 |
Korea United Pharm Inc |
Medicine inhaler
|
RS65562B1
(sr)
|
2015-06-15 |
2024-06-28 |
Glaxosmithkline Ip Dev Ltd |
Nrf2 regulatori
|
CN107709306A
(zh)
|
2015-06-15 |
2018-02-16 |
葛兰素史密斯克莱知识产权发展有限公司 |
Nrf2调节剂
|
JP6786527B2
(ja)
|
2015-06-15 |
2020-11-18 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーター
|
WO2016202800A1
(en)
|
2015-06-16 |
2016-12-22 |
Almirall, S.A. |
Pyrrolotriazinone derivatives as pi3k inhibitors
|
CN107614037B
(zh)
*
|
2015-07-29 |
2021-09-03 |
正大天晴药业集团股份有限公司 |
药物释放带
|
UY36851A
(es)
|
2015-08-16 |
2017-03-31 |
Glaxosmithkline Ip Dev Ltd |
Compuestos para uso en aplicaciones antibacterianas
|
KR20180052762A
(ko)
|
2015-09-22 |
2018-05-18 |
글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 |
브로모도메인 억제제로서 사용하기 위한 피리디논 디카르복스아미드
|
US10364256B2
(en)
|
2015-10-06 |
2019-07-30 |
Glaxosmithkline Intellectual Property Development Limited |
Biaryl pyrazoles as NRF2 regulators
|
WO2017060855A1
(en)
|
2015-10-06 |
2017-04-13 |
Glaxosmithkline Intellectual Property Development Limited |
Arylcyclohexyl pyrazoles as nrf2 regulators
|
WO2017085692A1
(en)
|
2015-11-18 |
2017-05-26 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Pharmaceutical compositions of ribavirin
|
GB201604680D0
(en)
|
2016-03-21 |
2016-05-04 |
Glaxosmithkline Ip Dev Ltd |
Chemical Compounds
|
EP3440075B1
(en)
|
2016-04-07 |
2020-01-29 |
GlaxoSmithKline Intellectual Property (No. 2) Limited |
Benzo[b]furans as bromodomain inhibitors
|
EP3440069B1
(en)
|
2016-04-07 |
2020-10-28 |
GlaxoSmithKline Intellectual Property (No. 2) Limited |
Pyridyl derivatives as bromodomain inhibitors
|
WO2017176291A1
(en)
*
|
2016-04-08 |
2017-10-12 |
Kendra Baldwin T |
Wearable wrist inhaler
|
US10844015B2
(en)
|
2016-05-24 |
2020-11-24 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Pyridine dicarboxamide derivatives as bromodomain inhibitors
|
GB201614940D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
GB201614934D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
GB201614939D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Ip Dev Ltd |
Crystalline hydrate
|
WO2018055526A1
(en)
|
2016-09-20 |
2018-03-29 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Trpv4 antagonists
|
EP3515889A1
(en)
|
2016-09-20 |
2019-07-31 |
GlaxoSmithKline Intellectual Property (No. 2) Limited |
Trpv4 antagonists
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產(第二)有限公司 |
Trpv4拮抗劑
|
CN109045427B
(zh)
*
|
2016-10-03 |
2021-06-25 |
捷普科技(上海)有限公司 |
药剂分配器
|
WO2018094392A1
(en)
|
2016-11-21 |
2018-05-24 |
Lupin Inc. |
Medicament dispenser
|
WO2018104766A1
(en)
|
2016-12-06 |
2018-06-14 |
Glaxosmithkline Intellectual Property Development Limited |
3-(2,3-dihydro-1h-inden-5-yl)propanoic acid derivatives and their use as nrf2 regulators
|
JP2020500919A
(ja)
|
2016-12-12 |
2020-01-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
Nrf2レギュレーターとしての3−カルボン酸ピロール
|
WO2018109642A1
(en)
|
2016-12-12 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
N-aryl pyrazoles as nrf2 regulators
|
ES2848699T3
(es)
|
2016-12-14 |
2021-08-11 |
Glaxosmithkline Ip Dev Ltd |
Compuestos de 3-oxo-1,4-diazepinilo como activadores de NRF2
|
WO2018109647A1
(en)
|
2016-12-14 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl amides as nrf2 regulators
|
US11117905B2
(en)
|
2016-12-14 |
2021-09-14 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl heterocycles as NRF2 activators
|
EP3555104B1
(en)
|
2016-12-15 |
2021-11-24 |
GlaxoSmithKline Intellectual Property Development Limited |
Nrf2 compounds
|
EP3555082B1
(en)
|
2016-12-15 |
2022-01-26 |
GlaxoSmithKline Intellectual Property Development Limited |
Ether linked triazoles as nrf2 regulators
|
US10702495B2
(en)
|
2017-02-20 |
2020-07-07 |
Nexien Biopharma, Inc. |
Method and compositions for treating dystrophies and myotonia
|
GB201703282D0
(en)
|
2017-03-01 |
2017-04-12 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
CN108622469B
(zh)
*
|
2017-03-24 |
2023-08-15 |
李和伟 |
一种独立包装的履带式给药器
|
US11167022B2
(en)
|
2017-03-31 |
2021-11-09 |
Glaxosmithkline Intellectual Property Development Limited |
Immunogenic composition, use and method of treatment
|
SG11201909478UA
(en)
|
2017-04-24 |
2019-11-28 |
Cocrystal Pharma Inc |
Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
|
AU2018308199B2
(en)
|
2017-07-25 |
2023-08-31 |
Adherium (Nz) Limited |
Adherence monitoring method and device
|
TW201919682A
(zh)
|
2017-08-08 |
2019-06-01 |
西班牙商阿爾米雷爾有限公司 |
活化Nrf2路徑的新穎化合物
|
GB201716369D0
(en)
|
2017-10-06 |
2017-11-22 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
GB201716392D0
(en)
|
2017-10-06 |
2017-11-22 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Compounds
|
US20210177861A1
(en)
|
2017-12-11 |
2021-06-17 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
WO2019116231A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
BR112020014431A2
(pt)
|
2018-01-17 |
2020-12-01 |
Glaxosmithkline Intellectual Property Development Limited |
inibidores de pl4kiiibeta
|
CN110237373B
(zh)
*
|
2018-03-08 |
2023-06-02 |
润生药业有限公司 |
一种生产用于联合用药的药物载体的装置及方法
|
US20210085897A1
(en)
|
2018-04-06 |
2021-03-25 |
Lupin Inc. |
Medicament dispenser
|
EP3796906A1
(en)
|
2018-05-23 |
2021-03-31 |
GlaxoSmithKline Intellectual Property Management Limited |
Indanes as nrf2 activators
|
MX2021000917A
(es)
|
2018-07-27 |
2021-06-23 |
Cocrystal Pharma Inc |
Derivados de pirrolo[2,3-b]piridina como inhibidores de la replicación del virus de la gripe.
|
GB201812671D0
(en)
|
2018-08-03 |
2018-09-19 |
Coalesce Product Dev Ltd |
An inhaler device
|
GB201814167D0
(en)
|
2018-08-31 |
2018-10-17 |
Glaxosmithkline Ip No 2 Ltd |
Compounds
|
NZ773698A
(en)
|
2018-09-10 |
2024-02-23 |
Cipla Ltd |
Single blister-strip based dispenser
|
JP7472108B2
(ja)
|
2018-09-10 |
2024-04-22 |
コクリスタル ファーマ,インコーポレイテッド |
ピリドピラジン系及びピリドトリアジン系インフルエンザウィルス複製阻害剤
|
MX2021004215A
(es)
|
2018-10-17 |
2021-07-15 |
Cocrystal Pharma Inc |
Combinaciones de inhibidores de la replicación del virus de la gripe.
|
AU2019380421A1
(en)
|
2018-11-13 |
2021-06-03 |
Cocrystal Pharma, Inc. |
Formulations of influenza therapeutics
|
WO2020112716A1
(en)
|
2018-11-26 |
2020-06-04 |
Cocrystal Pharma, Inc. |
Inhibitors of influenza virus replication
|
CA3138530A1
(en)
|
2019-04-29 |
2020-11-05 |
Insmed Incorporated |
Dry powder compositions of treprostinil prodrugs and methods of use thereof
|
EP3750528A1
(en)
|
2019-06-11 |
2020-12-16 |
Nexien Biopharma, Inc. |
Compositions for treating dystrophies and myotonia
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
EP4114743A1
(en)
|
2020-03-06 |
2023-01-11 |
Vectura Delivery Devices Limited |
Process for manufacturing a blister strip for a dry powder inhaler
|
US20230151034A1
(en)
|
2020-03-17 |
2023-05-18 |
Cocrystal Pharma, Inc. |
Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replication
|
CA3176877A1
(en)
|
2020-03-25 |
2021-09-30 |
Lupin Inc. |
Multi-carrier medicament dispensers
|
AU2021254045A1
(en)
|
2020-04-10 |
2022-10-13 |
Cocrystal Pharma, Inc. |
Inhibitors of norovirus and coronavirus replication
|
WO2021216547A1
(en)
|
2020-04-20 |
2021-10-28 |
Sorrento Therapeutics, Inc. |
Pulmonary administration of ace2 polypeptides
|
EP4061457A1
(en)
|
2020-06-15 |
2022-09-28 |
Norton (Waterford) Limited |
Blister pack and inhaler comprising the same
|
PL244222B1
(pl)
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
PL244221B1
(pl)
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
WO2022175425A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
|
JP2024510717A
(ja)
|
2021-02-22 |
2024-03-11 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
免疫原性組成物、使用及び方法
|
WO2022179967A1
(en)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat for treating covid-19 in a hospitalized subject
|
TW202321196A
(zh)
|
2021-08-03 |
2023-06-01 |
美商共結晶製藥公司 |
冠狀病毒抑制劑
|
KR20240045294A
(ko)
|
2021-08-13 |
2024-04-05 |
노턴 (워터포드) 리미티드 |
건조 분말 약제 흡입기
|
GB202111658D0
(en)
|
2021-08-13 |
2021-09-29 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
WO2023052476A1
(en)
|
2021-09-29 |
2023-04-06 |
Norton (Waterford) Limited |
Dry powder medicament inhaler
|
CA3227858A1
(en)
|
2021-09-29 |
2023-04-06 |
Norton (Waterford) Limited |
Dry powder medicament inhaler
|
GB202113921D0
(en)
|
2021-09-29 |
2021-11-10 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
CN114178071B
(zh)
*
|
2021-12-10 |
2022-09-09 |
杭州博乐工业设计股份有限公司 |
一种可更换储液设备的喷雾器
|
WO2023150747A1
(en)
|
2022-02-07 |
2023-08-10 |
Insmed Incorporated |
Dry powder compositions of bedaquiline and salts and methods of use thereof
|
GB2618145A
(en)
*
|
2022-04-29 |
2023-11-01 |
Merxin Ltd |
Manifold
|